Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway

Cervical cancer (CC) is the 4(th) most prevalent malignancy in females. This study explored the mechanism of everolimus (RAD001) combined with programmed death-1 (PD-1) blockade on radiosensitivity by phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathwa...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Lili, Liu, Shikai, Zhao, Sufen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208494/
https://www.ncbi.nlm.nih.gov/pubmed/35485300
http://dx.doi.org/10.1080/21655979.2022.2064205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208494/
https://www.ncbi.nlm.nih.gov/pubmed/35485300
http://dx.doi.org/10.1080/21655979.2022.2064205

Ejemplares similares